On the contrary, Ma and colleagues showed that SIRT-5 downregulation promotes insulin secretion from β-cells, suggesting inhibition of SIRT5 as a therapeutical approach for T2D [167]. The gene discussed is INS; the disease is type 2 diabetes mellitus.